Darktrace, the world’s leading AI company for cyber defense, has today announced that the UK’s National Health Service is increasing its adoption of Darktrace’s AI technology to safeguard systems and patient information, including prescription and blood type data.

In 2017, the WannaCry ransomware attack spread globally and implicated 61 NHS organizations. Darktrace Antigena successfully interrupted the attack across the NHS, driving the adoption of autonomous response technology that can fight back against in-progress attacks in seconds.

Autonomous response is the future for defending against fast-moving and unpredictable threats, before they do damage,” said Craig York, Associate Director of IT at Milton Keynes University Hospital NHS Foundation Trust. “I am confident that we will be in a much better place to fend off another serious cyber-attack on the NHS with Darktrace at work.”

Milton Keynes University Hospital NHS Foundation Trust, Royal Free London NHS Foundation Trust, Luton and Dunstable Hospital, and West Suffolk NHS Foundation Trust are just four NHS organizations enhancing their cyber security strategy with the Enterprise Immune System.

Today, cyber defenders have to react with the speed and accuracy of machines to keep our healthcare services and patients safe,” said Dave Palmer, Director of Technology, Darktrace. “As our hospitals and clinics become increasingly digitized and hyperconnected, it is reassuring to see more and more NHS organizations deploying Darktrace’s AI to catch sophisticated attacks, before they have the chance to cause a crisis.”

Darktrace is sponsoring the NHS 70th Anniversary Reception taking place in London today, on the theme of ‘Developing a Digital Future’.